The board meeting for Aurinia Pharma Inc is scheduled for today, for the purpose of Aurinia Pharmaceuticals Inc Annual General Meeting for 2026See details
Aurinia Pharma Inc has a share price target of US$ 17, revenue growth forecast of 14.6%, and profit growth estimate of -53.9% for FY26, based on top 7 analyst calls.